EUCTR2013-001304-11-ES
Active, not recruiting
Not Applicable
Evaluation of myocardial and clinical beneficial effect of sevoflurane in intraoperative and postoperative myocardial revascularization surgery, compared with propofol
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud0 sitesAugust 14, 2013
ConditionsAssessment of the beneficial effects of sevoflurane during the intraoperative and immediate postoperative myocardial revascularization surgery. Assessment will be through biochemical markers of myocardial injury and dysfunctionTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Assessment of the beneficial effects of sevoflurane during the intraoperative and immediate postoperative myocardial revascularization surgery. Assessment will be through biochemical markers of myocardial injury and dysfunction
- Sponsor
- Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
- Status
- Active, not recruiting
- Last Updated
- 12 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Elective off\-pump CABG.
- •2\.EUROSCORE (European level of risk, useful in the perioperative period of cardiac surgery patients, validated medical and scientific level) under 8 (moderate risk in the perioperative cardiac).
- •3\. Anesthetic risk level according to the American Society of Anesthesia (ASA) of less than 4 (moderate anesthetic risk patient\-high).
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 100
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •1\. History of adverse reaction to the various anesthetic drugs.
- •2\. Severe disease of any organ (lung, liver, kidney), diagnosed preoperatively.
- •3\. Combined surgery (eg valve repair or carotid surgery).
- •4\. Patients in hemodynamic instability.
- •5\. Heart failure or need for use of inotropes or vasoactive before surgery.
- •6\. Treatment with oral antidiabetics suspended at least 48 hours before.
- •7\. Treatment eufilina / theophylline before surgery.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study to evaluate cardiac function parameters by acoustic cardiography for patients with acute decompensated heart failureacute decompensated haert failureJPRN-UMIN000027945Juntendo University Graduate School of Medicine60
Completed
Not Applicable
Evaluation of efficacy in improvement of cardiac function / renal function by REZALTAS COMBINATION TABLETS on hypertension patient.hypertensionJPRN-UMIN000005140Kanazawa Medical University Hospital60
Completed
Not Applicable
The effects of cardiac rehabilitation in patients with chest pain after coronary stentingRecurrence of symptoms after percutaneous coronary intervention.presence of coronary angioplasty implant and graftIRCT2015042421921N1Shiraz University of Medical Sciences50
Completed
Not Applicable
Remote ischaemic postconditioning in the clinical settingTopic: Cardiovascular, NeurologicalSubtopic: Cardiovascular (all Subtopics), Neurological (all Subtopics)Disease: Cardiovascular, Nervous system disordersCirculatory SystemMyocardial ischaemia-reperfusion injuryISRCTN78348355niversity College London (UCL) (UK)500
Not yet recruiting
Phase 1
Clinical trial on the safety of myocardium regenerative therapy for ischemic heart disease using biodegradable polymeric carrier and basic fibroblast growth factorIschemic heart diseaseJPRN-UMIN000018709Kyoto University Graduate School of Medicine Department of Cardiovascular Surgery5